Benefit-Risk Frameworks May Be Coming To US FDA Advisory Committees

 
• By Sue Sutter
  
3D illustration of a benefits versus risks matrix with pills and tablets positioned on it. Evaluation of drugs, healthcare concept
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet